Records containing: Soft Tissue Sarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-03-18Integrated Biomarker PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas Using a Novel PET/CT Tracer
-
CLINICAL_TRIALS study record update · 2021-01-22DVT Prophylaxis in Orthopaedic Oncology Patients - A Safety Study
-
CLINICAL_TRIALS study record update · 2020-12-10A Phase II Trial of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas in Adults
-
CLINICAL_TRIALS study record update · 2020-10-28A Phase Ⅱ ,Open-label ,Single Institution Study to Investigate the Efficacy and Safety of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2020-10-19Ferumoxytol-Enhanced Magnetic Resonance Imaging (MRI) in Pediatric and Adult Patients With Malignant Sarcoma: A Two-part Pilot Study for Safety and Efficacy in the Pediatric and Adult Populations
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-10-14Genetic and Telomere Characteristics of High of Grade Soft Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2020-10-09Young Adult Cancer Survivor Network Study of the Essential Elements of Care (YA-EEC-14)
-
CLINICAL_TRIALS study record update · 2020-10-08Inzisionelle Negative Drucktherapie Nach Resektion Von Weichteiltumoren - Eine Prospektive, Randomisierte, Kontrollierte Klinische Studie
-
CLINICAL_TRIALS study record update · 2020-09-29SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas
-
CLINICAL_TRIALS study record update · 2020-09-21Starting Recovery Pre-operatively: Feasibility of Implementing Individualized Prehabilitation for People Scheduled for Lower Limb Soft-tissue Sarcoma Surgery
-
CLINICAL_TRIALS study record update · 2020-09-17A Phase 1 Study of SGN-CD47M in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-10A Phase 1b Study of Olaratumab, Doxorubicin and Ifosfamide in the Treatment of Patients With Advanced or Metastatic Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2020-06-17Neoadjuvant Intralesional Injection of Talimogene Laherparepvec With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2020-06-09A Phase II Study of Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
-
CLINICAL_TRIALS study record update · 2020-04-24Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
-
CLINICAL_TRIALS study record update · 2020-04-22Pegylated-liposome Doxorubicin Combined With Ifosfamide As First-line Treatment for Patients With Advanced or Metastatic Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2020-04-16A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy and Safety of CMB305 in Unresectable Locally-advanced or Metastatic NY-ESO-1+ Synovial Sarcoma Participants Following First Line Systemic Anti-cancer Therapy (V943-003, IMDZ-04-1702)
-
CLINICAL_TRIALS study record update · 2020-02-28A Phase 1b/2 Dose-Escalation and Expansion Trial of NC-6300 (Nanoparticle Epirubicin) in Patients With Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2020-02-13HYPAZ: An Open-label Investigation Into Hypertension Induced by Pazopanib Therapy
-
CLINICAL_TRIALS study record update · 2020-01-28FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans (FLASH)- A Feasibility Dose Escalation Study
-
CLINICAL_TRIALS study record update · 2020-01-27Peripheral Circulating Blood Tumor Cells (CTC) Detection and CTC-based PD-L1 Antibody Immunofluorescence Detection to PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Second-line and Back-line Treatment of Advanced NSCLC, Soft Tissue Sarcoma, Uterine Cancer Clinical Research
-
CLINICAL_TRIALS study record update · 2019-12-17A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin Plus Olaratumab Versus Doxorubicin Plus Placebo in Patients With Advanced or Metastatic Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2019-10-24Phase 1 Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Soft Tissue Sarcoma and Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2019-10-15Single-center, Open, Non-randomized, Phase II Prospective Study of Apatinib Combined With Chemotherapy in the Treatment of Unresectable Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2019-08-12A Phase 1b Trial to Assess the Modulation of Biological Markers in Patients With Potentially Resectable Soft Tissue Sarcoma Treated With Olaratumab Monotherapy Followed by Olaratumab Plus Doxorubicin Combination Therapy